Table 1.

Patient characteristics

RT/temozolomideVandetanib/RT/temozolomide
N = 36N = 70P
Median age, y (range)55 (23–73)59 (23–83)
Median KPS (range)90 (60–100)90 (60–100)
Gender, Female19 (52.8%)26 (37.1%)0.1
Race0.7
 White32/36 (88.9%)64/70 (91.4%)
 African American1/36 (2.8%)2/70 (2.9%)
 Asian2/36 (5.6%)1/70 (1.4%)
 Other1/36 (2.8%)3/70 (4.3%)
Extent of Resection0.4
 Gross total resection10/29 (34.5%)38/67 (56.7%)
 Subtotal resection13/29 (44.8%)16/67 (23.9%)
 Biopsy6/29 (20.7%)13/67 (19.4%)